Formats: Text / Subjects: Biomarkers and Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy - Digital Collections - National Library of Medicine Search Results

Start Over Formats Text ✖ Subjects Biomarkers ✖ Subjects Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy ✖

1. Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment